FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and In 2026, the question "Are peptides legal?" has been answered with a decisive regulatory crackdown. , The FDA has moved beyond general oversight into targeted enforcement. Popular wellness FDA issued a warning letter to a medical spa for failing to follow requirements that help ensure prescription drugs are safe and come from verified sources. These safeguards protect patients from potentially New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, FTC and U.S. FDA Warning Letter re: Products Containing CBD October 22, 2019